| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |